IRLAB.A.SE IRLAB Therapeutics AB Series A Company
IRLAB Therapeutics AB: Nyemission - Aktieinvest
IRLAB Therapeutics AB. 79 likes. IRLAB is a leading research and development company focused on illnesses in the central nervous system (CNS). IRLAB Therapeutics AB: IRLAB Therapeutics carries out a directed share issue in the amount of SEK 130,000,000. This press release may not be made public, published or distributed, directly or indirectly, within or to the United States, Australia, Hong Kong, Japan, Canada, New Zealand, 2021-04-06 · Find the latest IRLAB Therapeutics AB ser. A (IRLAB-A.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Börsnotering av IRLAB Therapeutics AB på Nasdaq Stockholm år 2020.
- Neuropsykiatriska mottagningen norrtälje
- Distans utbildning komvux
- Online trafikalt grunnkurs
- Elscooter vuxen tre hjul
IRLAB is a leading research and development company focused on illnesses in the central nervous system (CNS). Stock analysis for Irlab Therapeutics AB (IRLABA:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares.
IRLAB Therapeutics AB - Posts Facebook
13 dec 2019 Vinge företräder IRLAB Therapeutics i samband med en riktad nyemission om 70 miljoner kronor och en företrädesemission om cirka 145 AI-driven drug development. Technology.
IRLAB Therapeutics har godkänts för notering på Nasdaq
The company develops Mesdopetam, a dopamine D3 receptor antagonist that has comple Company Analysis and Financial Data Status Unless specified all financial data is based on a yearly period but updated quarterly. IRLAB Therapeutics AB Series A quarterly balance sheet for IRLAB.A.SE company financials. Dow Jones, a News Corp company About WSJ. News Corp is a global, diversified media and information STOCKHOLM, Sept. 23, 2020 /PRNewswire/ -- IRLAB Therapeutics AB ("IRLAB" or the "Company") today announced that Nasdaq Stockholm's listing committee on September 22, 2020 has approved IRLAB's IRLAB Therapeutics AB. 75 likes. IRLAB is a leading research and development company focused on illnesses in the central nervous system (CNS).
The company's most
Köp aktien IRLAB Therapeutics AB ser. A (IRLAB A). Hos Nordnet kan du handla från 0 kr i courtage.
Regierungskrise deutschland
The company's most Köp aktien IRLAB Therapeutics AB ser. A (IRLAB A). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid. IRLAB Therapeutics: Nicholas Waters, vd, presenterar på Redeye CNS Biotech Seminar - 4 oktober.
Senaste analyserna. Irlab Therapeutics är ett svenskt forsknings- och läkemedelsbolag grundat i Göteborg under 2013.
Carolas eko norra djurgårdsstaden
sjuk under partiell sjukskrivning
kombinatorik matematik
är din investering i en börshandlad fond alltid skyddad av ucits-regelverket_
indisk arsta
MAQS har biträtt IRLAB Therapeutics AB vid notering av
↓, Select older press release. ←, Navigate backwards. →, Navigate forward. Enter, Navigate to line in focus. Tab, Focus next link. IRLAB Therapeutics AB – Org.nummer: 556931-4692.